CIK: 0001609251 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 15, 2024
Total Value ($000): $218 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EXEL | EXELIXIS INC | 1,677,393 | $38 | 17.3% | $18.73 | +18.4% | COM | 30161Q104 |
| UTHR | UNITED THERAPEUTICS CORP | 118,208 | $38 | 17.3% | $127.97 | +106.8% | COM | 91307C102 |
| BIIB | BIOGEN INC | 123,785 | $29 | 13.2% | $267.94 | -18.9% | COM | 09062X103 |
| — | TARO PHARMACEUTICAL INDUS | 650,089 | $28 | 12.8% | $67.97 | — | COM | M8737E108 |
| CAH | CARDINAL HEALTH INC | 217,656 | $21 | 9.8% | $56.53 | +75.5% | COM | 14149Y108 |
| ENTA | ENANTA PHARMACEUTICALS INC | 1,251,338 | $16 | 7.5% | $30.17 | -55.3% | COM | 29251M106 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 109,076 | $12 | 5.3% | $123.69 | -11.1% | COM | G50871105 |
| BNTX | BIONTECH SE-ADR | 132,293 | $11 | 4.9% | $0.09 | — | COM | 09075V102 |
| REGN | REGENERON PHARMACEUTICALS | 7,853 | $8 | 3.8% | $342.96 | +181.1% | COM | 75886F107 |
| SNY | SANOFI-ADR | 153,832 | $7 | 3.4% | $0.05 | — | COM | 80105N105 |
| ALKS | ALKERMES PLC | 257,554 | $6 | 2.8% | $18.83 | +30.3% | COM | G01767105 |
| VNDA | VANDA PHARMACEUTICALS INC | 662,166 | $4 | 1.7% | $5.16 | 0.0% | COM | 921659108 |
| — | MURAL ONCOLOGY PLC | 75,057 | $0 | 0.1% | $0.01 | — | COM | G63365103 |